Want to see NL:CRBN full AI Analyst Report?
CRBN Stock Chart & Stats
€18.74
-€0.03(-0.16%)
At close: 4:00 PM EDT
€18.74
-€0.03(-0.16%)
Day’s Range― - ―
52-Week Range€16.16 - €21.96
Previous CloseN/A
Volume103.79K
Average Volume (3M)126.91K
Market Cap
€1.09B
Enterprise Value€1.66K
Total Cash (Recent Filing)€36.00M
Total Debt (Recent Filing)€517.60M
Price to Earnings (P/E)17.5
Beta0.97
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.38%
Share Statistics
EPS (TTM)1.08
Shares Outstanding58,250,310
10 Day Avg. Volume117,838
30 Day Avg. Volume126,914
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€24.00Price Target Upside28.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.32
Revenue Forecast (FY)€1.27B
Bulls Say, Bears Say
Bulls Say
Deleveraging / Improved LeverageMaterial debt reduction over two years materially lowers balance-sheet risk and increases financial flexibility. Lower leverage improves capacity to invest in R&D or capacity, supports consistent debt servicing and reduces refinancing pressure through cycles, aiding long-term stability.
Consistent Positive Cash GenerationSustained operating cash flow and multi-year positive free cash flow support internal funding for maintenance, strategic projects, and shareholder returns. Reliable cash conversion even after prior swings signals improved cash discipline and resilience to fund operations without excessive external financing.
Stable Specialty Bio-based Business ModelA focused specialty ingredients and biobased chemicals model relies on long-term B2B contracts and structural demand for sustainability and food preservation. This entrenched customer base and product specialization provide durable revenue streams and differentiated offerings versus commodity chemical peers.
Bears Say
Multi-year Revenue DeclineSerial revenue declines over multiple years indicate persistent demand or competitive challenges that can erode scale benefits. Continued top-line weakness constrains margin expansion, reduces absolute cash flow upside, and limits the payoff from prior investments absent a clear recovery in volumes or pricing.
Earnings Volatility / Uneven Net IncomeEpisodic swings in net income reduce earnings predictability and complicate capital allocation. Volatility can stem from one-offs, cyclical end-markets or margin pressure; it makes budgeting, dividend sustainability and long-term return assumptions less reliable for investors and management alike.
Shrinking Asset Base And Unclear Returns SustainabilityA declining asset base may reflect capacity reductions, divestments, or underinvestment, which can limit growth potential. Coupled with uncertainty over whether prior strong returns are repeatable, this raises questions about long-term reinvestment opportunities and the durability of improved profitability.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €16.16 and its highest was €21.96 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.09B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Feb 26, 2027 which is in 202 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Jul 31, 2026. The company reported €0.52 earnings per share for the quarter, beating the consensus estimate of €0.49 by €0.03.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Notavailable dividend of €1 which represents an annual dividend yield of 3.38%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.52 in its last earnings report, beating expectations of €0.49. Following the earnings report the stock price went down -2.923%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. It operates through the following segments: Food and Biochemicals. The Food segment provides biobased ingredients for the food industry. The Biochemicals segment produces chemicals derived from organic acids through the fermentation of carbohydrates, and lactic acid based solutions. The company was founded on August 21, 1919 and is headquartered in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€24.00
▲(28.07% Upside)